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Prostaglandin (PG) E2 manifest its biological activity by
signalling via four G protein coupled receptors (GPCRs)
identified as EP1, EP2, EP3 and EP4. GPCRs represent
the most numerous class of receptors in the mammalian
genome. Ligand binding to the GPCR results in the acti-
vation of the Gas subunit and disassociation of the Gas
and Gbgsubunits. Early on the binding of b-arrestin1 or
2 to the GPCR was thought to terminate GPCR signal-
ling by preventing further G protein interaction and to
cause receptor internalization/desensitization. However,
recent studies have indicated that the GPCR/b-arrestin1
or 2 interactions can actually provide a mechanism for
GPCR-mediated signalling.
In the research to be presented, the signalling path-
ways activated by butaprost, an EP2 agonist, and EP2’s
contributions to keratinocyte replication and skin tumor
development are described. Butaprost stimulation of
EP2 led to the activation of PKA and down stream
effectors. In addition, butaprost stimulation of EP2 led
to EP2-b-arrestin1 complex formation with subsequent
Src activation and transactivation of EGFR and down
stream effectors. The necessity for b-arrestin1 in the
activation of Src/EGFR was indicated by the significantly
decreased activation of Src/EGFR and down stream
effectors in b-arrestin1-/- mouse skin. In addition, selec-
tive inhibition of PKA, EGFR or the use of b-arrestin1-/-
mice significantly reduced mouse skin tumor formation.
Thus, the data indicate that the PGE2 receptor, EP2,
plays an important role in skin tumor formation; and
that both G protein dependent and b-arrestin1 depen-
dent signalling pathways are involved.
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